APR 16, 2020 6:09 AM PDT

This drug hopes to prevent cancer relapse

A report published in Nature Communications highlights findings from a study showing that the experimental drug, Quisinostat, could help stop cancer relapses. Conducted by researchers at Francis Crick Institute, the study demonstrated that Quisinostat stopped the re-growth of tumors after treatment in mice. It also served detain the growth of human cancer cells in culture.

Recurrence, or relapse, is a scary prospect for any cancer patient. While an individual who has completed a cancer therapy treatment could be in remission, a recurrence could be possible because of surviving cancer cells that grow into new tumors.

Lead author Cristina Morales Torres is the Principal Laboratory Research Scientist in the Cancer Epigenetics Laboratory at the Crick. She and her team think that Quisinostat has a wide therapeutic benefit because its effect doesn’t depend on how cancer cells survived initial treatment and it doesn’t harm healthy cells.

She commented, "This drug works by disabling the cells that fuel long-term cancer growth and drive disease relapse. These early findings even suggest it may be more effective than commonly used drugs that inhibit tumor growth. Further research is still needed to confirm whether this drug could prevent cancer coming back in people or if it could be used to control someone's disease long term."

More specifically, the drug increases the amount of a protein called histone H1.0 within the tumor cells, which stops the cancer cells from replicating. The researchers showed that this was effective not only in tumors in mice but also in human cells with breast, lung or pancreatic cancer.

The fear of relapse plagues many cancer patients. Photo: Pixabay

Co-author Paola Scaffidi, Group Leader of the Cancer Epigenetics Laboratory at the Crick and Professorial Research Associate at the UCL Cancer Institute, says: "Just like stem cells that continuously produce progeny to keep our normal tissues healthy, cancer cells grow, divide and use energy. That's why finding a potential drug that halts tumor growth without hurting normal cells has been a challenge. Excitingly, with Quisinostat, we've seen no harm to healthy stem cells in our initial studies."

The researchers believe that Quisinostat is a viable option that could be given to cancer patients after having completed initial treatment. As they write, they hope that “sequential administration of targeted therapy and Quisinostat may be a broadly applicable strategy to induce a prolonged response in patients.”

Sources: Nature Communications, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
NOV 25, 2020
Cancer
Using RNA to Diagnose HPV Associated Cancer
NOV 25, 2020
Using RNA to Diagnose HPV Associated Cancer
Diagnostic tools are critical to modern medicine. They might be less exciting than a good therapy or drug, but doctors a ...
NOV 23, 2020
Cancer
Where are the geographic hotspots of high mortality rates for women with colorectal cancer?
NOV 23, 2020
Where are the geographic hotspots of high mortality rates for women with colorectal cancer?
A study published in Clinical and Translational Gastroenterology highlights the risk disparities in death rates fro ...
DEC 02, 2020
Cancer
Telomere shortening doesn't only indicate ageing...
DEC 02, 2020
Telomere shortening doesn't only indicate ageing...
While telomere shortening has been thought to be an adverse sign of aging, new research suggests that the shortening of ...
DEC 08, 2020
Cancer
Stress hormones interrupt tumor cells' hibernation
DEC 08, 2020
Stress hormones interrupt tumor cells' hibernation
A new study published in Science Translational Medicine suggests that the hormones released from stress could “rea ...
DEC 26, 2020
Clinical & Molecular DX
Navigating the Genomic Landscape of Cancer in Asians
DEC 26, 2020
Navigating the Genomic Landscape of Cancer in Asians
Precision medicine — a clinical paradigm that tailors treatments specifically to patients based on their genetic a ...
JAN 20, 2021
Genetics & Genomics
Mutations in One Gene Can Lead to Cancer in Different Ways
JAN 20, 2021
Mutations in One Gene Can Lead to Cancer in Different Ways
Cancer and genetics are linked; for example, when a cell's genome accumulates mutations it can begin to divide uncon ...
Loading Comments...